SABCS: Younger Postmenopausal Breast Cancer Patients Can Avoid Adjuvant RT

For postmenopausal women aged 50 to 69 years with stage 1 hormone receptor-positive breast cancer, the risk for recurrence is very low for those who do not undergo radiotherapy after BCS.

Related Keywords

San Antonio ,Texas ,United States ,Reshma Jagsi ,Emory University In Atlanta ,Healthday News ,Clinical Oncology ,San Antonio Breast Cancer Symposium ,Emory University ,Recurrence Score ,